protect
rescu
reintroduct
test
role
human
influenza
viru
infect
assess
allel
individu
hospitalis
season
pandem
influenza
virus
find
statist
signific
number
hospitalis
subject
show
enrich
minor
allel
snp
alter
splice
acceptor
site
function
assay
show
minor
cc
genotyp
reduc
influenza
viru
restrict
vitro
togeth
data
reveal
action
singl
intrins
immun
effector
profoundli
alter
cours
influenza
viru
infect
mous
man
identifi
function
genom
screen
mediat
resist
influenza
viru
dengu
viru
west
nile
viru
infect
vitro
howev
role
ifitm
protein
antivir
immun
vivo
unknown
therefor
infect
mice
homozyg
disrupt
insert
exon
gene
abolish
express
lowpathogen
lp
murineadapt
influenza
viru
lp
strain
influenza
normal
caus
extens
viral
replic
throughout
lung
caus
cytokin
dysregul
death
typic
seen
infect
highlypathogen
hp
viral
strain
dose
use
fig
howev
lpinfect
mice
becam
moribund
lose
origin
bodi
weight
exhibit
sever
sign
clinic
ill
rapid
breath
piloerect
day
infect
comparison
wildtyp
wt
litter
mate
shed
origin
bodi
weight
fulli
recov
fig
b
littl
differ
viru
replic
lung
first
hour
infect
howev
viru
persist
clear
quickli
mice
whose
lung
contain
higher
level
replic
viru
wt
mice
day
postinfect
fig
viral
rna
detect
heart
brain
spleen
infect
wt
mice
cours
infect
reveal
system
viremia
occur
full
genom
sequenc
viru
remov
lung
wt
mice
show
genet
variat
demonstr
protein
express
influenza
infect
absent
mice
increas
substanti
wt
control
fig
supp
fig
infect
wt
mice
human
isol
pandem
influenza
result
sever
pathogen
phenotyp
mice
fig
b
mous
embryon
fibroblast
mef
line
gener
multipl
match
litterm
demonstr
cell
infect
readili
vitro
lack
much
protect
effect
interferon
ifn
importantli
stabl
restor
confer
wt
level
restrict
either
pathogen
puerto
influenza
strain
fig
supp
fig
role
restrict
hp
avian
influenza
also
show
limit
infect
recent
human
influenza
isol
influenza
b
viru
supp
fig
therefor
enhanc
pathogenesi
divers
influenza
virus
attribut
loss
express
consequenti
chang
immun
defenc
lung
examin
lung
patholog
show
fulmin
viral
pneumonia
substanti
damag
sever
inflamm
infect
mice
lung
patholog
characteris
extens
oedema
red
blood
cell
extravas
well
pneumonia
hemorrhag
pleural
effus
multipl
larg
lesion
lung
lobe
fig
b
supp
fig
note
patholog
similar
produc
infect
mice
primat
viru
given
higher
viral
load
mice
increas
replic
influenza
viru
delet
cell
vitro
fig
examin
viral
nucleic
acid
protein
distribut
lung
influenza
viru
infect
penetr
deeper
lung
tissu
compar
wt
mice
whose
infect
primarili
restrict
bronchiol
minim
alveolar
infect
influenza
viru
detect
throughout
entir
lung
section
spread
extens
bronchiol
alveoli
fig
histopatholog
show
mark
infiltr
cell
debri
europ
pmc
funder
author
manuscript
bronchoalveolar
space
mice
fig
supp
fig
extent
mechan
cell
damag
investig
tunel
assay
show
widespread
cellular
apoptosi
occur
day
postinfect
mice
wherea
apoptosi
wt
lung
limit
supp
fig
togeth
mous
patholog
consist
infect
hp
strain
influenza
viru
widespread
apoptosi
occur
day
postinfect
whilst
lung
lp
infect
similar
wt
mice
display
minim
damag
analysi
cell
popul
resid
lung
tissu
day
postinfect
show
mice
display
significantli
reduc
proport
tcell
natur
killer
nk
cell
elev
proport
neutrophil
fig
despit
extens
cellular
infiltr
supp
fig
absolut
number
tlymphocyt
lung
mice
also
lower
neutrophil
increas
compar
wt
mice
supp
fig
peripher
blood
infect
mice
show
leukopenia
supp
fig
blood
differenti
cell
count
indic
mark
deplet
lymphocyt
day
postinfect
mice
fig
reflect
chang
observ
previous
hp
lp
influenza
infect
human
anim
model
heighten
cytokin
chemokin
level
also
hallmark
sever
influenza
infect
observ
human
anim
model
observ
exagger
proinflammatori
respons
lung
mice
higher
level
gcsf
show
mark
chang
fig
supp
fig
indic
extent
viral
spread
within
lung
releas
cell
upon
infect
consist
immunopatholog
data
chang
compar
level
seen
hp
influenza
infect
neutrophil
chemotaxi
togeth
elev
proinflammatori
cytokin
secret
previous
report
one
primari
caus
acut
lung
injuri
investig
extens
pathogenesi
observ
lp
influenza
viru
infect
absenc
infect
wt
mice
influenza
strain
defici
multifunct
gene
primari
influenza
viru
interferon
antagonist
multipl
inhibitori
effect
host
immun
pathway
found
viru
attenu
wt
mice
whilst
isogen
strain
express
exhibit
typic
high
pathogen
mice
test
lower
dose
influenza
whilst
lethal
genotyp
mice
caus
acceler
weight
loss
compar
wt
mice
supp
fig
influenza
viru
retain
pathogen
ifndefici
mice
suggest
mice
mount
adequ
ifnmedi
antivir
respons
without
extens
morbid
therefor
uncheck
lung
viral
replic
enhanc
inflammatori
respons
account
profoundli
deleteri
effect
viral
infect
mice
human
gene
two
exon
predict
encod
two
splice
variant
differ
presenc
absenc
first
ntermin
amino
acid
fig
current
nonsynonym
synonym
one
infram
stop
one
splice
site
acceptoralt
singl
nucleotid
polymorph
snp
report
translat
sequenc
supp
tabl
use
test
sensit
recent
posit
select
find
evid
posit
select
locu
human
popul
act
last
ten
thousand
year
africa
fig
c
therefor
sequenc
locu
encompass
exon
intron
untransl
region
individu
requir
admiss
hospit
result
pandem
season
influenza
viru
infect
patient
carri
major
allel
snp
code
sequenc
gene
possess
known
variant
particular
discov
overrepresent
case
synonym
snp
wherein
major
allel
substitut
minor
c
allel
alter
first
splice
acceptor
site
may
associ
splice
variant
encod
protein
lack
first
amino
acid
due
use
altern
start
codon
allel
frequenc
snp
vari
differ
human
popul
supp
tabl
ancestr
c
allel
report
chimpanze
rare
subsaharan
african
european
popul
deriv
allel
frequenc
daf
respect
frequent
popul
supp
tabl
snp
notabl
high
level
differenti
european
east
asian
although
fixat
index
f
st
measur
popul
differenti
reach
statist
signific
genotyp
associ
caucasian
hospitalis
follow
influenza
infect
differ
significantli
ethnic
match
european
genom
sequenc
data
genotyp
imput
june
releas
genom
phase
haplotyp
uk
netherland
germani
netherland
germani
fisher
exact
test
patient
genotyp
also
depart
hardi
weinberg
equilibrium
show
excess
c
allel
popul
fig
princip
compon
analysi
autosom
snp
show
evid
hidden
popul
structur
differ
wtccc
control
subset
hospitalis
individu
studi
supp
fig
b
test
function
signific
polymorph
vitro
confirm
genotyp
hapmap
lymphoblastoid
cell
line
lcl
homozyg
either
major
tt
minor
cc
variant
allel
supp
fig
next
challeng
lcl
influenza
viru
found
minor
cc
variant
suscept
infect
vulner
correl
lower
level
protein
express
compar
major
tt
variant
cell
supp
fig
although
detect
splice
variant
protein
cc
lcl
nonetheless
investig
possibl
signific
presenc
stabli
express
ntermin
truncat
wt
protein
equival
level
human
lung
carcinoma
cell
line
infect
influenza
viru
found
cell
express
protein
fail
restrict
viral
replic
compar
wt
show
express
act
essenti
barrier
influenza
viru
infect
vivo
vitro
fulmin
viral
pneumonia
occur
absenc
aris
uncontrol
viru
replic
lung
result
profound
morbid
effect
host
loss
singl
immun
effector
transform
mild
infect
one
remark
sever
similarli
enrich
callel
hospitalis
influenza
infect
togeth
decreas
level
increas
infect
ccallel
cell
vitro
suggest
also
play
pivot
role
defenc
human
influenza
viru
infect
innat
resist
factor
import
encount
novel
pandem
viru
host
acquir
immun
defenc
less
effect
inde
individu
turn
popul
higher
percentag
individu
may
vulner
initi
establish
spread
viru
lack
adapt
immun
light
abil
curtail
replic
broad
rang
pathogen
virus
vitro
vivo
result
suggest
may
also
shape
clinic
cours
addit
viral
infect
favour
host
may
done
human
evolutionari
histori
backgroundmatch
wt
mice
made
describ
weight
record
daili
monitor
sign
ill
mice
exceed
total
weight
loss
kill
accord
uk
home
offic
guidelin
litterm
control
use
experi
lung
five
mice
per
genotyp
collect
day
postinfect
weigh
homogenis
weight
volum
wv
leibovitz
medium
invitrogen
contain
antibioticantimycot
invitrogen
sampl
quantifi
viral
load
plaqu
assay
serial
dilut
madindarbi
canin
kidney
mdck
cell
monolay
overlaid
avicel
medium
lung
subject
two
freezethaw
cycl
titrat
viru
also
quantifi
rtqpcr
wherein
rna
first
extract
lung
heart
brain
spleen
use
rneasi
mini
plu
kit
qiagen
purifi
rna
normalis
mass
quantifi
sybr
green
qiagen
use
manufactur
instruct
primer
influenza
matrix
protein
fw
rv
sigmaaldrich
mous
actb
fw
rv
qpcr
perform
steponeplu
machin
appli
biosystem
analys
stepon
softwar
appli
biosystem
lung
homogenis
wv
tissu
protein
extract
reagent
thermo
scientif
contain
complet
proteas
inhibitor
roch
total
protein
quantifi
bca
assay
thermo
scientif
normalis
load
well
protein
visualis
follow
indic
primari
antibodi
mous
rabbit
polyclon
purchas
santa
cruz
biotechnolog
cat
antifragili
rabbit
polyclon
antibodi
abcam
cat
western
blot
use
stabl
cell
line
probe
antibodi
prosci
cat
recognis
conserv
portion
protein
still
present
even
absenc
first
twenti
one
ntermin
amino
acid
lcl
blot
includ
cell
line
lysat
control
probe
either
antibodi
specif
nterminu
rabbit
nterm
aa
abgent
antibodi
prosci
cat
well
rabbit
proteintech
mous
antigapdh
clone
sigma
lcl
immunoblot
antibodi
dilut
dpb
sigma
contain
tween
sigma
nonfar
dri
milk
carnat
incub
overnight
primari
antibodi
consequ
bound
correspond
speciesappropri
hrpconjug
secondari
antibodi
dako
actin
antibodi
purchas
either
abcam
sigma
mous
monoclon
cat
section
paraffinembed
tissu
stain
hematoxylin
eosin
sigmaaldrich
examin
score
twice
pathologist
blind
condit
tunel
assay
apoptosi
conduct
use
tac
xl
dab
situ
apoptosi
detect
kit
r
system
lung
tissu
embed
glycol
methacryl
gma
visualis
spread
viral
protein
describ
previous
briefli
section
block
sodium
azid
hydrogen
peroxid
follow
second
block
rpmi
invitrogen
contain
fetal
calf
serum
sigmaaldrich
bovin
serum
albumen
invitrogen
viral
antigen
stain
use
polyclon
antibodi
influenza
b
takara
visualis
secondari
goat
antirabbit
antibodi
conjug
ap
dako
section
counterstain
hematoxylin
sigmaaldrich
murin
protein
express
lung
section
either
uninfect
mice
two
day
postinfect
immunostain
either
antibodi
abcam
cat
antifragili
rabbit
polyclon
antisera
abcam
cat
section
also
stain
dna
hoechst
sigma
viral
rna
visualis
paraffinembed
section
use
quantigen
viewrna
kit
affymetrix
briefli
section
rehydr
incub
proteinas
k
subsequ
incub
viewrna
probe
set
design
neg
strand
vrna
encod
np
gene
affymetrix
signal
amplifi
incub
label
probe
visualis
singl
cell
suspens
gener
pass
lung
twice
filter
lyse
red
blood
cell
rbc
lysi
buffer
ebiosci
assess
cell
viabil
via
trypan
blue
exclus
cell
characteris
flow
cytometri
follow
tlymphocyt
tlymphocyt
activ
neutrophil
hi
dendrit
cell
lo
lo
mhc
class
ii
high
macrophag
hi
natur
killer
cell
antibodi
supp
tabl
bd
bioscienc
except
abd
serotec
sampl
run
facsaria
ii
bd
bioscienc
visualis
use
flowjo
data
analys
statist
graph
use
prism
graphpad
softwar
mice
per
genotyp
per
day
bled
day
tail
vein
punctur
leukocyt
count
determin
haemocytomet
whilst
blood
cell
differenti
count
calcul
count
duplic
blood
smear
stain
wrightgiemsa
stain
sigmaaldrich
least
leukocyt
count
per
smear
blood
analys
conduct
blind
fashion
data
analys
statist
graph
use
prism
graphpad
softwar
lung
collect
homogenis
day
postinfect
four
mice
genotyp
gcsf
gmcsf
kclike
rant
analys
use
mous
antibodi
bead
kit
millipor
accord
manufactur
instruct
luminex
result
analys
qualiti
control
check
use
masterplex
qt
masterplex
readerfit
miraibio
data
analys
statist
graph
use
prism
graphpad
softwar
adult
mice
intercross
fibroblast
mef
deriv
embryo
day
gestat
describ
previous
mef
genotyp
pcr
thermostart
taq
dna
polymeras
abgen
epsom
uk
embryo
tail
genom
dna
use
primer
cycl
profil
describ
previous
recruit
patient
confirm
season
influenza
b
viru
pandem
influenza
infect
requir
hospitalis
england
scotland
novemb
februari
patient
signific
risk
factor
sever
diseas
patient
whose
daili
activ
limit
comorbid
ill
exclud
patient
male
femal
averag
age
rang
select
concurr
comorbid
remain
follow
comorbid
condit
hypertens
patient
alcohol
depend
cerebrovascular
diseas
patient
bipolar
disord
patient
kyphoscoliosi
patient
four
patient
pregnant
assess
patient
normal
bodi
mass
one
bmi
bmi
one
bmi
season
influenza
influenza
b
pandem
influenza
confirm
local
viral
pcr
serolog
test
accord
region
protocol
consent
obtain
directli
compet
patient
relativesfriendswelfar
attorney
incapacit
patient
anonymis
edta
blood
sampl
transport
ambient
temperatur
dna
extract
use
nucleon
kit
genprob
protocol
dna
sampl
resuspend
ml
te
buffer
ph
triscl
ph
edta
ph
human
sequenc
amplifi
dna
obtain
peripher
blood
nest
pcr
genbank
access
number
first
round
utilis
primer
fw
rv
follow
addit
round
use
primer
fw
rv
band
gel
extract
purifi
use
qiaquick
gel
extract
kit
qiagen
sanger
sequenc
appli
biosystem
dna
analyz
gatc
biotech
use
combin
eight
sequenc
primer
supp
tabl
singl
nucleotid
polymorph
identifi
assembl
human
encod
refer
sequenc
acc
use
lasergen
dnastar
homozygot
call
base
high
singl
base
peak
high
phred
qualiti
score
whilst
heterozygot
identifi
base
low
overlap
peak
two
base
lower
phred
qualiti
score
rel
surround
base
call
supp
fig
identifi
snp
sequenc
compar
allel
genotyp
frequenc
allel
genotyp
frequenc
genom
sequenc
data
differ
popul
supp
tabl
addit
use
recent
releas
phase
genom
data
imput
region
surround
snp
determin
allel
frequenc
publicli
avail
genotyp
dataset
control
four
previous
publish
dataset
genotyp
netherland
germani
imput
sampl
genotyp
illumina
platform
imput
june
releas
genotyp
phase
haplotyp
use
imput
softwar
assess
popul
stratif
princip
compon
analysi
genotyp
data
birth
cohort
dataset
obtain
european
genotyp
archiv
permiss
reformat
merg
genotyp
data
genisi
studi
match
snp
present
cohort
suspect
strand
mismatch
remov
identifi
snp
genotyp
use
ld
method
implement
plink
result
match
snp
qualiti
control
appli
genabel
version
genotyp
data
snp
genisi
case
individu
wtccc
threshold
qualiti
control
deviat
hardyweinberg
equilibrium
p
maf
call
rate
sampl
appli
iter
identifi
marker
subject
pass
qualiti
control
criteria
follow
princip
compon
analysi
use
genabel
test
posit
select
use
haplotypebas
test
xpehhmax
allel
frequenc
spectrumbas
test
statist
name
tajima
fay
wu
h
nielsen
et
al
clr
kb
window
across
entir
genom
describ
previous
three
statist
combin
combin
p
valu
plot
correspond
kb
window
author
contribut
gd
alb
pk
design
studi
po
gd
alb
pk
